NATCO 15 (Lansoprazole Delayed-Release 15 mg)
Pill with imprint NATCO 15 is Green & Pink, Capsule-shape and has been identified as Lansoprazole Delayed-Release 15 mg. It is supplied by Breckenridge Pharmaceutical, Inc..
Lansoprazole is used in the treatment of gerd; barrett's esophagus; duodenal ulcer; aspiration pneumonia; duodenal ulcer prophylaxis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for NATCO 15
More about lansoprazole
- Lansoprazole Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- 75 Reviews
- Drug class: proton pump inhibitors
- Lansoprazole Orally Disintegrating Tablets
- Lansoprazole Delayed-Release Capsules
- Lansoprazole (Advanced Reading)
Related treatment guides
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.